Compare WKEY & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WKEY | ALPS |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | Switzerland | Malaysia |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 66.6M |
| IPO Year | 2019 | 2024 |
| Metric | WKEY | ALPS |
|---|---|---|
| Price | $5.66 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.7K | ★ 60.1K |
| Earning Date | 09-30-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $64.54 | N/A |
| Revenue Next Year | $52.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.32 | $0.23 |
| 52 Week High | $19.80 | $1.72 |
| Indicator | WKEY | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 50.35 |
| Support Level | $5.74 | $0.38 |
| Resistance Level | $6.94 | $0.44 |
| Average True Range (ATR) | 0.29 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 36.23 | 47.47 |
WISeKey International Holding Ltd at the forefront of authentication and cybersecurity technology. It develops, markets, hosts, and supports a range of solutions that enable the secure digital identification and communication of people, content, and objects, by generating digital identities that enable its clients to monetize their existing user bases and, at the same time, expand their own eco-system securely by ensuring only authenticated objects and people can connect. The WISeKey Group operates through five core verticals: SEALSQ, WISeSat, SEALCOIN, WISeID, & WISe.ART. It has two business segments. Semiconductors & ASICs. The majority of its revenue is generated from the Semiconductors segment.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.